GSK (GlaxoSmithKline) is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.
In the US, we have about 15,000 employees and 21 sites total, including 10 manufacturing sites across the country. We have a network of scientists working in the US at our Global Pharma R&D hub in Upper Providence (Pennsylvania) and our Global Vaccines R&D Center in Rockville (Maryland).
Five Moore Drive
P.O. Box 13398
Research Triangle Park, NC 27709
+1 (919) 483-2100
We are on the cusp of a major, positive disruption in the U.S. health care system due in part to the exponential growth in clinical data, advent and incorporation of artificial intelligence and the increasing realignment of the health care sector.
At a recent event held by The Atlantic, scientists and researchers joined others in the biopharmaceutical industry to discuss genomics' ever-evolving and critically important role in treating disease.
<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>READ MORE
<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>READ MORE
<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>READ MORE